Chemotherapy: The standard of care for all in 2013 -is combination of chemotherapies. Rituxan (rituximab) which is an antibody againsts cd 20 will be incoorporated to the chemo regimen if cancer expressing cd20 +. Genetic profiling evaluation is very important in acute leukemia-not only for prognosis but also hopefully soon to help us in treatment selection. Discuss in detail with your oncologist/hematologist.
Answered 7/1/2014
5.2k views
5 doctors weighed in across 3 answers
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question